Tazarotene
Back to searchMolecule Structure
Scientific Name
Tazarotene
Description of the Drug
Tazarotene is an acetylenic retinoid used to treat fine wrinkles, mottled pigmentation of the skin, acne vulgaris, and plaque psoriasis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00799
http://www.drugbank.ca/drugs/DB00799
Brand Name(s)
Arazlo, Avage, Fabior, Tazorac, Zorac
Company Owner(s)
Fougera Pharmaceuticals Inc, Bausch Health Americas Inc, Mayne Pharma Llc, Allergan Inc, Taro Pharmaceuticals Inc, Cosette Pharmaceuticals Inc, Bausch Health Us Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Retinoic acid receptor | PROTEIN FAMILY | AGONIST | CHEMBL2363069 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL3134 | ||||
| PharmGKB | PA164746821 | ||||
| Human Metabolome Database | HMDB0014937 | ||||
| DrugBank | DB00799 | ||||
| PubChem: Thomson Pharma | 14754274 | ||||
| PubChem | 5381 | ||||
| LINCS | LSM-45376 | ||||
| Nikkaji | J679.813F | ||||
| BindingDB | 50265951 | ||||
| EPA CompTox Dashboard | DTXSID5046691 | ||||
| DrugCentral | 2571 | ||||
| ChemicalBook | CB7405439 | ||||
| Guide to Pharmacology | 6952 | ||||
| rxnorm | ARAZLO | FABIOR | AVAGE | TAZAROTENE | TAZORAC |
| PubChem: Drugs of the Future | 12014289 | ||||
| KEGG Ligand | C12531 | ||||
| ChEBI | 32184 | ||||
| ZINC | ZINC000001542199 |
